Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Thrombocytopenia and MGMT[original query] |
---|
Apatinib Plus Temozolomide: An Effective Salvage Treatment for Recurrent Glioblastoma. Frontiers in oncology 2021 2 10 601175. Ge Jingjing, Li Cheng, Xue Fengjun, Qi Shaopei, Gao Zhimeng, Yu Chunjiang, Zhang Junpi |
Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825. Neuro-oncology advances 2022 10 4 (1): vdac152. Scheurer Michael E, Zhou Renke, Gilbert Mark R, Bondy Melissa L, Sulman Erik P, Yuan Ying, Liu Yanhong, Vera Elizabeth, Wendland Merideth M, Youssef Emad F, Stieber Volker W, Komaki Ritsuko R, Flickinger John C, Kenyon Lawrence C, Robins H Ian, Hunter Grant K, Crocker Ian R, Chao Samuel T, Pugh Stephanie L, Armstrong Terri |
Temozolomide-induced myelotoxicity and single nucleotide polymorphisms in the MGMT gene in patients with adult diffuse glioma: a single-institutional pharmacogenetic study. Journal of neuro-oncology 2022 1 156 (3): 625-634. Moitra Prithwijit, Chatterjee Abhishek, Kota Priti Khatri, Epari Sridhar, Patil Vijay, Dasgupta Archya, Kowtal Pradnya, Sarin Rajiv, Gupta Tejp |
- Page last reviewed:Feb 1, 2024
- Content source: